The APOBEC (apolipoprotein B mRNA editing catalytic polypeptide-like) family of proteins have diverse and important functions in human health and disease. These proteins have an intrinsic ability to bind to both RNA and single-stranded (ss) DNA. Both function and tissue-specific expression varies widely for each APOBEC protein. We are beginning to understand that the activity of APOBEC proteins is regulated through genetic alterations, changes in their transcription and mRNA processing, and through their interactions with other macromolecules in the cell. Loss of cellular control of APOBEC activities leads to DNA hypermutation and promiscuous RNA editing associated with the development of cancer or viral drug resistance, underscoring the importance of understanding how APOBEC proteins are regulated.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930407 | PMC |
| http://dx.doi.org/10.1016/j.tibs.2016.05.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
APOBEC3A deaminates CTG hairpin loops to promote fragility and instability of expanded CAG/CTG repeats.
Proc Natl Acad Sci U S A
January 2025
Program in Genetics, Molecular, and Cellular Biology, Tufts University Graduate School of Biomedical Sciences, Boston, MA 02111.
CAG/CTG repeats are prone to expansion, causing several inherited human diseases. The initiating sources of DNA damage which lead to inaccurate repair of the repeat tract to cause expansions are not fully understood. Expansion-prone CAG/CTG repeats are actively transcribed and prone to forming stable R-loops with hairpin structures forming on the displaced single-stranded DNA (S-loops).
View Article and Find Full Text PDFERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers.
Breast Cancer Res
December 2024
Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, MA, 02129, USA.
Background: The HOXB13/IL17RB gene expression biomarker has been shown to predict response to adjuvant and extended endocrine therapy in patients with early-stage ER+ HER2- breast tumors. HOXB13 gene expression is the primary determinant driving the prognostic and endocrine treatment-predictive performance of the biomarker. Currently, there is limited data on HOXB13 expression in HER2+ and ER- breast cancers.
View Article and Find Full Text PDFADAR1 could be a potential diagnostic target for intrauterine infection patients.
Sci Rep
November 2024
Department of Obstetrics and Gynecology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Article Synopsis
- Intrauterine infection (IUI) involves pathogens ascending from the vagina and cervix to the uterus, affecting the fetus, but effective diagnostic biomarkers for related conditions like chorioamnionitis (CAM) and funisitis (FUN) are lacking.
- A study analyzed the role of specific RNA editing molecules, particularly ADAR1, in tissue samples from 83 patients, finding that ADAR1 showed higher diagnostic capability compared to other markers.
- Ureaplasma parvum was found to activate ADAR1 in a cell line study, while high levels of ADAR1 expression were significantly linked to CAM and FUN cases, suggesting it could serve as a potential diagnostic target for IUI.*
Viral N protein hijacks deaminase-containing RNA granules to enhance SARS-CoV-2 mutagenesis.
EMBO J
December 2024
School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
Article Synopsis
- Host cell-encoded deaminases, like APOBEC and ADAR, inhibit SARS-CoV-2 replication by introducing mutations into the viral genome.
- The SARS-CoV-2 nucleocapsid (N) protein interacts with these deaminases at stress granules to promote viral RNA mutagenesis, a process essential for blocking infection.
- A specific residue (F17) in the N protein is crucial for this interaction, as mutations affecting this residue reduce the ability of N protein to localize with deaminases and subsequently lower viral RNA mutagenesis.
Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma.
EMBO J
January 2025
School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Two APOBEC DNA cytosine deaminase enzymes, APOBEC3A and APOBEC3B, generate somatic mutations in cancer, thereby driving tumour development and drug resistance. Here, we used single-cell RNA sequencing to study APOBEC3A and APOBEC3B expression in healthy and malignant mucosal epithelia, validating key observations with immunohistochemistry, spatial transcriptomics and functional experiments. Whereas APOBEC3B is expressed in keratinocytes entering mitosis, we show that APOBEC3A expression is confined largely to terminally differentiating cells and requires grainyhead-like transcription factor 3 (GRHL3).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!